Connect with us
The Drug Enforcement Administration has rejected witnesses and testimony from the group fighting to keep two psychedelic compounds out of Schedule I. The agency has a...
Despite growing support at the federal level, the process likely won’t be completed until at least 2025. In a letter this week to the U.S. attorney...
If the public comments are any indication, the Drug Enforcement Administration’s proposal to reschedule cannabis is well on its way to approval. The government agency has...
The U.S. Government Accountability Office (GAO) told the Drug Enforcement Administration (DEA) that it needs to do a better job with religious exemption requests it gets...
The Drug Enforcement Administration (DEA) recently released a report on May 9 with details about its 2024 National Drug Threat Assessment (NDTA), which is dedicated to...
President Joe Biden announced that the U.S. Department of Justice will officially reschedule cannabis, moving it from Schedule I, reserved for dangerous drugs with no medical...
The firm is arguing the DEA’s administrative rulemaking process has been unlawful and would hamper its research efforts. A Drug Enforcement Administration judge has postponed a...
